89 related articles for article (PubMed ID: 9474887)
1. [Hodgkin's disease: a mystery is being solved].
Stein H; Hummel M; Marafioti T; Korbjuhn P; Anagnostopoulos I; Foss HD
Verh Dtsch Ges Pathol; 1997; 81():327-38. PubMed ID: 9474887
[TBL] [Abstract][Full Text] [Related]
2. Cellular origin and clonality of classic Hodgkin's lymphoma: immunophenotypic and molecular studies.
Stein H; Hummel M
Semin Hematol; 1999 Jul; 36(3):233-41. PubMed ID: 10462323
[TBL] [Abstract][Full Text] [Related]
3. Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells.
Marafioti T; Hummel M; Anagnostopoulos I; Foss HD; Falini B; Delsol G; Isaacson PG; Pileri S; Stein H
N Engl J Med; 1997 Aug; 337(7):453-8. PubMed ID: 9250847
[TBL] [Abstract][Full Text] [Related]
4. Molecular biology of Hodgkin's disease.
Stein H; Hummel M; Marafioti T; Anagnostopoulos I; Foss HD
Cancer Surv; 1997; 30():107-23. PubMed ID: 9547989
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte-predominant Hodgkin's disease. An immunohistochemical analysis of 208 reviewed Hodgkin's disease cases from the German Hodgkin Study Group.
von Wasielewski R; Werner M; Fischer R; Hansmann ML; Hübner K; Hasenclever D; Franklin J; Sextro M; Diehl V; Georgii A
Am J Pathol; 1997 Mar; 150(3):793-803. PubMed ID: 9060817
[TBL] [Abstract][Full Text] [Related]
6. [Pathology of Hodgkin's lymphoma].
Hansmann ML; Willenbrock K
Verh Dtsch Ges Pathol; 2003; 87():53-7. PubMed ID: 16888894
[TBL] [Abstract][Full Text] [Related]
7. Typing the histogenetic origin of the tumor cells of lymphocyte-rich classical Hodgkin's lymphoma in relation to tumor cells of classical and lymphocyte-predominance Hodgkin's lymphoma.
Bräuninger A; Wacker HH; Rajewsky K; Küppers R; Hansmann ML
Cancer Res; 2003 Apr; 63(7):1644-51. PubMed ID: 12670918
[TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of the IgH gene in 212 cases of Hodgkin's disease: correlation of IgH clonality with the histologic and the immunocytochemical features.
Manzanal AI; Santón A; Acevedo A; Aguilera B; Oliva H; Bellas C
Mod Pathol; 1997 Jul; 10(7):679-85. PubMed ID: 9237178
[TBL] [Abstract][Full Text] [Related]
9. Rearrangement of immunoglobulin and T-cell receptor genes in Hodgkin's disease.
Roth MS; Schnitzer B; Bingham EL; Harnden CE; Hyder DM; Ginsburg D
Am J Pathol; 1988 May; 131(2):331-8. PubMed ID: 3358458
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of T-cell receptor gamma (TCRgamma) gene rearrangement on formalin-fixed, paraffin-embedded tissues by PCR assays.
Tai YC; Peh SC
Singapore Med J; 2003 May; 44(5):250-5. PubMed ID: 13677361
[TBL] [Abstract][Full Text] [Related]
11. Hodgkin's disease, lymphocyte-predominant type: immunoreactivity with B-cell antibodies.
Coles FB; Cartun RW; Pastuszak WT
Mod Pathol; 1988 Jul; 1(4):274-8. PubMed ID: 3266337
[TBL] [Abstract][Full Text] [Related]
12. Hodgkin's disease cell lines: a model for interleukin-1-independent accessory cell function.
McKenzie JL; Egner W; Calder VL; Hart DN
Immunology; 1992 Nov; 77(3):345-53. PubMed ID: 1478681
[TBL] [Abstract][Full Text] [Related]
13. Diffuse lymphocyte-predominant Hodgkin's disease (diffuse paragranuloma). A variant of the B-cell-derived nodular type.
Hansmann ML; Stein H; Dallenbach F; Fellbaum C
Am J Pathol; 1991 Jan; 138(1):29-36. PubMed ID: 1987769
[TBL] [Abstract][Full Text] [Related]
14. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
[TBL] [Abstract][Full Text] [Related]
15. Cellular origin of nodular lymphocyte-predominant Hodgkin's lymphoma: immunophenotypic and molecular studies.
Chan WC
Semin Hematol; 1999 Jul; 36(3):242-52. PubMed ID: 10462324
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus-negative Hodgkin's lymphoma after mycosis fungoides: molecular evidence for distinct clonal origin.
Kremer M; Sandherr M; Geist B; Cabras AD; Höfler H; Fend F
Mod Pathol; 2001 Feb; 14(2):91-7. PubMed ID: 11235910
[TBL] [Abstract][Full Text] [Related]
17. Hodgkin's disease-like lymphoproliferative disorders in patients with different underlying immunodeficiency states.
Tinguely M; Vonlanthen R; Müller E; Dommann-Scherrer CC; Schneider J; Laissue JA; Borisch B
Mod Pathol; 1998 Apr; 11(4):307-12. PubMed ID: 9578079
[TBL] [Abstract][Full Text] [Related]
18. The activation profile of tumour-associated reactive T-cells differs in the nodular and diffuse patterns of lymphocyte predominant Hodgkin's disease.
Lin P; Medeiros LJ; Wilder RB; Abruzzo LV; Manning JT; Jones D
Histopathology; 2004 Jun; 44(6):561-9. PubMed ID: 15186271
[TBL] [Abstract][Full Text] [Related]
19. A study of Hodgkin/Reed-Sternberg cells using single cell polymerase chain reaction.
Deng F; Liao L; Lü G; Li G; Yang G
Chin Med J (Engl); 2000 Jan; 113(1):65-9. PubMed ID: 11775214
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease.
Kanavaros P; Vlychou M; Stefanaki K; Rontogianni D; Gaulard P; Pantelidaki E; Zois M; Darivianaki K; Georgoulias V; Boulland ML; Gorgoulis V; Kittas C
Anticancer Res; 1999; 19(2A):1209-16. PubMed ID: 10368677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
